The indications and safety of rituximab for the treatment of pediatric autoimmune diseases: a single-center retrospective study
This study highlights both the varied indications for which RTX was prescribed and the need for vigilance concerning infusion-related adverse events. It underscores the importance of close monitoring and appropriate management to ensure the safety of RTX therapy in pediatric patients. Further research is warranted to optimize treatment strategies and enhance patient outcomes in this population.
Authors
- Saeed A Alhudaifi (ORCID: https://orcid.org/0000-0001-5279-3397)
- Mohammed Nashawi (ORCID: https://orcid.org/0000-0001-7580-2655)
- Mohammed A Alsubaie (ORCID: https://orcid.org/0000-0002-6098-0704)
- Faris Althubaiti (ORCID: https://orcid.org/0009-0007-3565-955X)
- Abdulaziz M. Alghamdi (ORCID: https://orcid.org/0009-0003-3606-5850)
- Abdulrahman B Bahkali
- Majed T Osaylan
Institutions
- King Abdulaziz University (SA)
Publication Details
- Journal
- Translational Pediatrics
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tp-24-233
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.94